Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Structure Therapeutics Inc. - American Depositary Shares
(NQ:
GPCR
)
48.58
+0.41 (+0.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
785,052
Open
48.39
Bid (Size)
47.00 (5)
Ask (Size)
49.50 (10)
Prev. Close
48.17
Today's Range
47.13 - 49.91
52wk Range
25.57 - 75.02
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Could Structure Therapeutics Become the Next Novo Nordisk?
June 17, 2024
Becoming the next Novo Nordisk is a long shot, but it's more likely than it sounds.
Via
The Motley Fool
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
June 14, 2024
The company just unveiled preclinical results from a test of its GLP-1 weight-loss drug.
Via
Investor's Business Daily
Performance
YTD
+20.28%
+20.28%
1 Month
+35.77%
+35.77%
3 Month
+39.60%
+39.60%
6 Month
+43.60%
+43.60%
1 Year
+52.53%
+52.53%
More News
Read More
Structure Therapeutics Stock Could Rocket 87% Higher, According to 1 Wall Street Analyst. Is It Time to Buy?
June 11, 2024
Via
The Motley Fool
Skye Bioscience Pivots To Obesity After Glaucoma Flop; Shares Plummet
June 10, 2024
Via
Investor's Business Daily
Structure Therapeutics' Stock Is Soaring on the Promise of Its Wegovy Competitor, but Is It a Buy?
June 09, 2024
Via
The Motley Fool
Top Names Performance Update - Saturday, June 8
June 08, 2024
Via
Talk Markets
Week In Review: Structure Reports Efficacy Of Obesity Drug; Raises $476 Million
June 08, 2024
Via
Talk Markets
Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional American Depositary Shares
June 07, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering
June 05, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
The 3 Most Undervalued Biotech Stocks to Buy in June 2024
June 04, 2024
Via
InvestorPlace
Structure Therapeutics Announces Proposed Public Offering of American Depositary Shares and Pre-Funded Warrants
June 03, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics' Obesity Candidate Is ' Very Competitive' To Eli Lilly's Orforglipron, Analyst Says
June 03, 2024
Via
Benzinga
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
June 03, 2024
Via
Benzinga
Structure Therapeutics Stock Skyrockets To Six-Month High On Compelling Weight-Loss Drug Results
June 03, 2024
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
June 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 03, 2024
Via
Benzinga
Obesity Data From Structure Therapeutics Shows Potential For Weight Loss Drug Candidate
June 03, 2024
Via
Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
June 03, 2024
Via
Benzinga
Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290
June 03, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Unearthing Unknown Stocks: 3 Picks That Could Be the Next Big Thing
May 31, 2024
Via
InvestorPlace
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
May 21, 2024
Via
Benzinga
GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q1 2024
May 09, 2024
Via
InvestorPlace
Structure Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights
May 09, 2024
From
Structure Therapeutics Inc.
Via
GlobeNewswire
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
May 09, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.